CaraMed Capital logo

CaraMed Capital

Oceania, Auckland, New Zealand, Auckland

Description

CaraMed Capital is a deep-health tech venture capital fund.

Investor Profile

CaraMed Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in Australia.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Seed (100%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CaraMed Capital frequently co-invest with?

UNSW Founders
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Main Sequence Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 1

What are some of recent deals done by CaraMed Capital?

Psylo

Sydney, New South Wales, Australia

Psylo is a drug development company that focuses on next-generation psychedelics.

Biotechnology
SeedOct 27, 2022
Amount Raised: $3,225,276